SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma terminates agreement with Cronus Pharma

21 Aug 2021 Evaluate

Aurobindo Pharma has received an approval for termination of the binding agreements with Cronus Pharma Specialities India. The company had entered into binding agreements with Cronus Pharma Specialities for acquisition of 51% ownership in Cronus Pharma by subscribing to 95,059,963 equity shares of Rs 10 each at a premium of Rs.34.18 per equity share aggregating to Rs 420 crore. The board of Directors in its meeting held on August 20, 2021 has approved the termination of the aforesaid agreements.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1377.20 9.50 (0.69%)
21-Apr-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.80
Dr. Reddys Lab 1224.90
Cipla 1231.00
Zydus Lifesciences 931.55
Lupin 2324.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×